Global High Throughput Screening Market- Industry Analysis and Forecast (2020-2027)-by Product and Services, Technology, Application, End-User and Region.

Market Scenario

Global High Throughput Screening Market was valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 7.9% during a forecast period.   Product Definition High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are widely used in the pharmaceutical industry, leveraging robotics and automation to rapidly test the biological or biochemical activity of a large number of molecules, like drugs. HTS is a suitable tool for assessing, for example, pharmacological targets, pharmacologically profiling agonists and antagonists for receptors (such as GPCRs) and enzymes. Using robotics, liquid handling devices, data processing/control software, and sensitive detectors, high-throughput screening permits a researcher to rapidly conduct millions of genetic, chemical, or pharmacological tests. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Market Dynamics The Research Report gives a detailed account of the drivers and restraints in the high throughput screening market. High-throughput screening (HTS) is a process used in drug discovery to identify hits from compound libraries that may become leads for medicinal chemistry optimization. The initiatives are taken by pharmaceutical and biotechnology firms, rising R&D spending, technological developments in HTS, and the obtainability of government funding and undertaking capital investments. HTS is used in stem cell research for the identification of target hits, examination of functional activity; and the valuation of absorption, metabolism, distribution, and excretion characteristics. The use of human stem cells instead of mouse stem cells offers many opportunities for refining the clinical expectedness of preclinical drug discovery and development, which provides lots of opportunities in this market. However, HTS includes many steps like target selection and characterization, reagent preparation, assay development, compound screening, and hit validation in secondary assays. According to the complexity of the target and assay, their time and cost get vary. The process of reagent and assay development for primary and secondary makes it more costly. Additionally, HTS instruments, such as flow cytometers and liquid handlers, are too much costly. These factors restraints the growth of the High-throughput screening market. Global High Throughput Screening Market Segment analysis Based on Technology, the 3D cell segment is expected to grow at a CAGR of XX% during the forecast period. 3D cells show more realistic properties while testing in the natural environment and other cell-associated operations, supported for drug design and discovery. The growth of this segment is compelled mostly by the growing focus on developing replacements to animal testing, rising focus on modified drug, the up surging prevalence of chronic diseases, and the accessibility of funding for research. Normal differentiation and polarization of epithelial cells are vital for the formation of duct-like structures in vitro conditions, which can be achieved when the cells are cultivated in 3D cultures. Furthermore, the synergistic effect necessary for the interactions of cell-cell and cell-extracellular matrix (ECM), which can control the expression of molecules involved in cell differentiation, is accomplished in 3D cell cultures. Global High Throughput Screening Market Regional analysis The North American region has dominated the market with US$ XX Mn. North America is seen to be an important contributor to the market share, mostly owing to the prominence placed on research and development in pharmaceutical companies, the acceptance of drug detection techniques, government support, and funding and the great number of companies producing HTS products and services. European markets have a large share of the market because of advancements in chemical testing, development of software and hardware that can automate testing, government initiatives for drug testing, R&D by several research centers and the upsurge in the application of data processing software for HTS. Asia Pacific region has experienced a rising popularity of high throughput screening techniques. In 2018, Charles River Laboratories' total revenue was $2.3 billion was high as compared to Bio-Rad Laboratories. Bio-Rad Laboratories' annual revenue for 2018 was $2.289B. Key Agreements • In 2019: Charles River signed a binding offer to acquire Citoxlab which would enhance the Company’s ability to partner with clients across the drug discovery and development continuum. • In February 2018: Charles River Laboratories International, Inc. announced a new agreement, which grants Charles River commercial access to AstraZeneca’s high-throughput screening (HTS) and compound management infrastructure. • In 2018: Bio-Rad Laboratories Inc. announced an expanded global agreement with Abbott, providing their customers with wider access to Bio-Rad’s quality controls. Key Developments • On 22nd August 2019- New high-throughput screening identifies compounds that reduce viability specifically in liver cancer cells that express the high level of sall4 by inhibiting oxidative phosphorylation. • On 4 Feb 2019- Bio-Rad Laboratories, Inc., showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAs) in Washington, D.C. The ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening. New features offered by the ZE5 help accelerate biopharmaceutical drug discovery, allowing researchers to scale up to multiple assays, such as epitope binding or compound screening assays, when thousands of samples must be analyzed. • In 2018- The Life Science segment of Bio-Rad Laboratories, Inc., achieved some remarkable product launched with two new chromatographic media for process scale protein purification. The objective of the report is to present a comprehensive analysis of the Global High Throughput Screening Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global High Throughput Screening Market dynamics, structure by analysing the market segments and projects the Global High Throughput Screening Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global High Throughput Screening Market make the report investor’s guide.

Scope of the Global High Throughput Screening Market

Global High Throughput Screening Market, By Product and Services

• Reagents & Assay Kits • Instruments • Consumables & Accessories • Software • Services

Global High Throughput Screening Market, By Technology

• Cell-based Assays 2D Cell Culture   3D Cell Culture   Perfusion Cell Culture • Lab-on-a-chip (LOC) • Ultra-high-throughput Screening • Bioinformatics • Label-free Technology

Global High Throughput Screening Market, By Application

• Target Identification & Validation • Primary and Secondary Screening • Toxicology Assessment • Other Applications

Global High Throughput Screening Market, By End-User

• Pharmaceutical and Biotechnology Companies • Academic and Government Institutes • Contract Research Organizations • Other

Global High Throughput Screening Market, By Regions

• North America • Europe • Asia-Pacific • South America • Middle East and Africa (MEA)

Key Players operating the Global High Throughput Screening Market

• Agilent Technologies, Inc • Danaher Corporation • Perkinelmer, Inc • Thermo Fisher Scientific Inc • Axxam S.P.A • Tecan Group Ltd • Bio-Rad Laboratories, Inc • Hamilton Company • Sigma-Aldrich Corporation • Charles River Laboratories International, Inc

Table of Contents

Global High Throughput Screening Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global High Throughput Screening Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global High Throughput Screening Market Analysis and Forecast 6.1. High Throughput Screening Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global High Throughput Screening Market Analysis and Forecast, By Product and Services 7.1. Introduction and Definition 7.2. Key Findings 7.3. High Throughput Screening Market Value Share Analysis, By Product and Services 7.4. High Throughput Screening Market Size (US$ Mn) Forecast, By Product and Services 7.5. High Throughput Screening Market Analysis, By Product and Services 7.6. High Throughput Screening Market Attractiveness Analysis, By Product and Services 8. Global High Throughput Screening Market Analysis and Forecast, By Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. High Throughput Screening Market Value Share Analysis, By Technology 8.4. High Throughput Screening Market Size (US$ Mn) Forecast, By Technology 8.5. High Throughput Screening Market Analysis, By Technology 8.6. High Throughput Screening Market Attractiveness Analysis, By Technology 9. Global High Throughput Screening Market Analysis and Forecast, By End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. High Throughput Screening Market Value Share Analysis, By End-User 9.4. High Throughput Screening Market Size (US$ Mn) Forecast, By End-User 9.5. High Throughput Screening Market Analysis, By End-User 9.6. High Throughput Screening Market Attractiveness Analysis, By End-User 10. Global High Throughput Screening Market Analysis and Forecast, By Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. High Throughput Screening Market Value Share Analysis, By Application 10.4. High Throughput Screening Market Size (US$ Mn) Forecast, By Application 10.5. High Throughput Screening Market Analysis, By Application 10.6. High Throughput Screening Market Attractiveness Analysis, By Application 11. Global High Throughput Screening Market Analysis, By Region 11.1. High Throughput Screening Market Value Share Analysis, by Region 11.2. High Throughput Screening Market Size (US$ Mn) Forecast, by Region 11.3. High Throughput Screening Market Attractiveness Analysis, by Region 12. North America High Throughput Screening Market Analysis 12.1. Key Findings 12.2. North America High Throughput Screening Market Overview 12.3. North America High Throughput Screening Market Value Share Analysis, By Product and Services 12.4. North America High Throughput Screening Market Forecast, By Product and Services 12.4.1. Reagents & Assay Kits 12.4.2. Instruments 12.4.3. Consumables & Accessories 12.4.4. Software 12.4.5. Services 12.5. North America High Throughput Screening Market Value Share Analysis, By Technology 12.6. North America High Throughput Screening Market Forecast, By Technology 12.6.1. Cell-based Assays 12.6.1.1. 2D Cell Culture 12.6.1.2. 3D Cell Culture 12.6.1.3. Perfusion Cell Culture 12.6.2. Lab-on-a-chip (LOC) 12.6.3. Ultra-high-throughput Screening 12.6.4. Bioinformatics 12.6.5. Label-free Technology 12.7. North America High Throughput Screening Market Value Share Analysis, By End-User 12.8. North America High Throughput Screening Market Forecast, By End-User 12.8.1. Pharmaceutical and Biotechnology Companies 12.8.2. Academic and Government Institutes 12.8.3. Contract Research Organizations 12.8.4. Other 12.9. North America High Throughput Screening Market Value Share Analysis, By Application 12.10. North America High Throughput Screening Market Forecast, By Application 12.10.1. Target Identification & Validation 12.10.2. Primary and Secondary Screening 12.10.3. Toxicology Assessment 12.10.4. Other Applications 12.11. North America High Throughput Screening Market Value Share Analysis, by Country 12.12. North America High Throughput Screening Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America High Throughput Screening Market Analysis, by Country 12.14. U.S. High Throughput Screening Market Forecast, By Product and Services 12.14.1. Reagents & Assay Kits 12.14.2. Instruments 12.14.3. Consumables & Accessories 12.14.4. Software 12.14.5. Services 12.15. U.S. High Throughput Screening Market Forecast, By Technology 12.15.1. Cell-based Assays 12.15.1.1. 2D Cell Culture 12.15.1.2. 3D Cell Culture 12.15.1.3. Perfusion Cell Culture 12.15.2. Lab-on-a-chip (LOC) 12.15.3. Ultra-high-throughput Screening 12.15.4. Bioinformatics 12.15.5. Label-free Technology 12.16. U.S. High Throughput Screening Market Forecast, By End-User 12.16.1. Pharmaceutical and Biotechnology Companies 12.16.2. Academic and Government Institutes 12.16.3. Contract Research Organizations 12.16.4. Other 12.17. U.S. High Throughput Screening Market Forecast, By Application 12.17.1. Target Identification & Validation 12.17.2. Primary and Secondary Screening 12.17.3. Toxicology Assessment 12.17.4. Other Applications 12.18. Canada High Throughput Screening Market Forecast, By Product and Services 12.18.1. Reagents & Assay Kits 12.18.2. Instruments 12.18.3. Consumables & Accessories 12.18.4. Software 12.18.5. Services 12.19. Canada High Throughput Screening Market Forecast, By Technology 12.19.1. Cell-based Assays 12.19.1.1. 2D Cell Culture 12.19.1.2. 3D Cell Culture 12.19.1.3. Perfusion Cell Culture 12.19.2. Lab-on-a-chip (LOC) 12.19.3. Ultra-high-throughput Screening 12.19.4. Bioinformatics 12.19.5. Label-free Technology 12.20. Canada High Throughput Screening Market Forecast, By End-User 12.20.1. Pharmaceutical and Biotechnology Companies 12.20.2. Academic and Government Institutes 12.20.3. Contract Research Organizations 12.20.4. Other 12.21. Canada High Throughput Screening Market Forecast, By Application 12.21.1. Target Identification & Validation 12.21.2. Primary and Secondary Screening 12.21.3. Toxicology Assessment 12.21.4. Other Applications 12.22. North America High Throughput Screening Market Attractiveness Analysis 12.22.1. By Product and Services 12.22.2. By Technology 12.22.3. By End-User 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe High Throughput Screening Market Analysis 13.1. Key Findings 13.2. Europe High Throughput Screening Market Overview 13.3. Europe High Throughput Screening Market Value Share Analysis, By Product and Services 13.4. Europe High Throughput Screening Market Forecast, By Product and Services 13.4.1. Reagents & Assay Kits 13.4.2. Instruments 13.4.3. Consumables & Accessories 13.4.4. Software 13.4.5. Services 13.5. Europe High Throughput Screening Market Value Share Analysis, By Technology 13.6. Europe High Throughput Screening Market Forecast, By Technology 13.6.1. Cell-based Assays 13.6.1.1. 2D Cell Culture 13.6.1.2. 3D Cell Culture 13.6.1.3. Perfusion Cell Culture 13.6.2. Lab-on-a-chip (LOC) 13.6.3. Ultra-high-throughput Screening 13.6.4. Bioinformatics 13.6.5. Label-free Technology 13.7. Europe High Throughput Screening Market Value Share Analysis, By End-User 13.8. Europe High Throughput Screening Market Forecast, By End-User 13.8.1. Pharmaceutical and Biotechnology Companies 13.8.2. Academic and Government Institutes 13.8.3. Contract Research Organizations 13.8.4. Other 13.9. Europe High Throughput Screening Market Value Share Analysis, By Application 13.10. Europe High Throughput Screening Market Forecast, By Application 13.10.1. Target Identification & Validation 13.10.2. Primary and Secondary Screening 13.10.3. Toxicology Assessment 13.10.4. Other Applications 13.11. Europe High Throughput Screening Market Value Share Analysis, by Country 13.12. Europe High Throughput Screening Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe High Throughput Screening Market Analysis, by Country 13.14. Germany High Throughput Screening Market Forecast, By Product and Services 13.14.1. Reagents & Assay Kits 13.14.2. Instruments 13.14.3. Consumables & Accessories 13.14.4. Software 13.14.5. Services 13.15. Germany High Throughput Screening Market Forecast, By Technology 13.15.1. Cell-based Assays 13.15.1.1. 2D Cell Culture 13.15.1.2. 3D Cell Culture 13.15.1.3. Perfusion Cell Culture 13.15.2. Lab-on-a-chip (LOC) 13.15.3. Ultra-high-throughput Screening 13.15.4. Bioinformatics 13.15.5. Label-free Technology 13.16. Germany High Throughput Screening Market Forecast, By End-User 13.16.1. Pharmaceutical and Biotechnology Companies 13.16.2. Academic and Government Institutes 13.16.3. Contract Research Organizations 13.16.4. Other 13.17. Germany High Throughput Screening Market Forecast, By Application 13.17.1. Target Identification & Validation 13.17.2. Primary and Secondary Screening 13.17.3. Toxicology Assessment 13.17.4. Other Applications 13.18. U.K. High Throughput Screening Market Forecast, By Product and Services 13.18.1. Reagents & Assay Kits 13.18.2. Instruments 13.18.3. Consumables & Accessories 13.18.4. Software 13.18.5. Services 13.19. U.K. High Throughput Screening Market Forecast, By Technology 13.19.1. Cell-based Assays 13.19.1.1. 2D Cell Culture 13.19.1.2. 3D Cell Culture 13.19.1.3. Perfusion Cell Culture 13.19.2. Lab-on-a-chip (LOC) 13.19.3. Ultra-high-throughput Screening 13.19.4. Bioinformatics 13.19.5. Label-free Technology 13.20. U.K. High Throughput Screening Market Forecast, By End-User 13.20.1. Pharmaceutical and Biotechnology Companies 13.20.2. Academic and Government Institutes 13.20.3. Contract Research Organizations 13.20.4. Other 13.21. U.K. High Throughput Screening Market Forecast, By Application 13.21.1. Target Identification & Validation 13.21.2. Primary and Secondary Screening 13.21.3. Toxicology Assessment 13.21.4. Other Applications 13.22. France High Throughput Screening Market Forecast, By Product and Services 13.22.1. Reagents & Assay Kits 13.22.2. Instruments 13.22.3. Consumables & Accessories 13.22.4. Software 13.22.5. Services 13.23. France High Throughput Screening Market Forecast, By Technology 13.23.1. Cell-based Assays 13.23.1.1. 2D Cell Culture 13.23.1.2. 3D Cell Culture 13.23.1.3. Perfusion Cell Culture 13.23.2. Lab-on-a-chip (LOC) 13.23.3. Ultra-high-throughput Screening 13.23.4. Bioinformatics 13.23.5. Label-free Technology 13.24. France High Throughput Screening Market Forecast, By End-User 13.24.1. Pharmaceutical and Biotechnology Companies 13.24.2. Academic and Government Institutes 13.24.3. Contract Research Organizations 13.24.4. Other 13.25. France High Throughput Screening Market Forecast, By Application 13.25.1. Target Identification & Validation 13.25.2. Primary and Secondary Screening 13.25.3. Toxicology Assessment 13.25.4. Other Applications 13.26. Italy High Throughput Screening Market Forecast, By Product and Services 13.26.1. Reagents & Assay Kits 13.26.2. Instruments 13.26.3. Consumables & Accessories 13.26.4. Software 13.26.5. Services 13.27. Italy High Throughput Screening Market Forecast, By Technology 13.27.1. Cell-based Assays 13.27.1.1. 2D Cell Culture 13.27.1.2. 3D Cell Culture 13.27.1.3. Perfusion Cell Culture 13.27.2. Lab-on-a-chip (LOC) 13.27.3. Ultra-high-throughput Screening 13.27.4. Bioinformatics 13.27.5. Label-free Technology 13.28. Italy High Throughput Screening Market Forecast, By End-User 13.28.1. Pharmaceutical and Biotechnology Companies 13.28.2. Academic and Government Institutes 13.28.3. Contract Research Organizations 13.28.4. Other 13.29. Italy High Throughput Screening Market Forecast, By Application 13.29.1. Target Identification & Validation 13.29.2. Primary and Secondary Screening 13.29.3. Toxicology Assessment 13.29.4. Other Applications 13.30. Spain High Throughput Screening Market Forecast, By Product and Services 13.30.1. Reagents & Assay Kits 13.30.2. Instruments 13.30.3. Consumables & Accessories 13.30.4. Software 13.30.5. Services 13.31. Spain High Throughput Screening Market Forecast, By Technology 13.31.1. Cell-based Assays 13.31.1.1. 2D Cell Culture 13.31.1.2. 3D Cell Culture 13.31.1.3. Perfusion Cell Culture 13.31.2. Lab-on-a-chip (LOC) 13.31.3. Ultra-high-throughput Screening 13.31.4. Bioinformatics 13.31.5. Label-free Technology 13.32. Spain High Throughput Screening Market Forecast, By End-User 13.32.1. Pharmaceutical and Biotechnology Companies 13.32.2. Academic and Government Institutes 13.32.3. Contract Research Organizations 13.32.4. Other 13.33. Spain High Throughput Screening Market Forecast, By Application 13.33.1. Target Identification & Validation 13.33.2. Primary and Secondary Screening 13.33.3. Toxicology Assessment 13.33.4. Other Applications 13.34. Rest of Europe High Throughput Screening Market Forecast, By Product and Services 13.34.1. Reagents & Assay Kits 13.34.2. Instruments 13.34.3. Consumables & Accessories 13.34.4. Software 13.34.5. Services 13.35. Rest of Europe High Throughput Screening Market Forecast, By Technology 13.35.1. Cell-based Assays 13.35.1.1. 2D Cell Culture 13.35.1.2. 3D Cell Culture 13.35.1.3. Perfusion Cell Culture 13.35.2. Lab-on-a-chip (LOC) 13.35.3. Ultra-high-throughput Screening 13.35.4. Bioinformatics 13.35.5. Label-free Technology 13.36. Rest of Europe High Throughput Screening Market Forecast, By End-User 13.36.1. Pharmaceutical and Biotechnology Companies 13.36.2. Academic and Government Institutes 13.36.3. Contract Research Organizations 13.36.4. Other 13.37. Rest Of Europe High Throughput Screening Market Forecast, By Application 13.37.1. Target Identification & Validation 13.37.2. Primary and Secondary Screening 13.37.3. Toxicology Assessment 13.37.4. Other Applications 13.38. Europe High Throughput Screening Market Attractiveness Analysis 13.38.1. By Product and Services 13.38.2. By Technology 13.38.3. By End-User 13.38.4. By Application 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific High Throughput Screening Market Analysis 14.1. Key Findings 14.2. Asia Pacific High Throughput Screening Market Overview 14.3. Asia Pacific High Throughput Screening Market Value Share Analysis, By Product and Services 14.4. Asia Pacific High Throughput Screening Market Forecast, By Product and Services 14.4.1. Reagents & Assay Kits 14.4.2. Instruments 14.4.3. Consumables & Accessories 14.4.4. Software 14.4.5. Services 14.5. Asia Pacific High Throughput Screening Market Value Share Analysis, By Technology 14.6. Asia Pacific High Throughput Screening Market Forecast, By Technology 14.6.1. Cell-based Assays 14.6.1.1. 2D Cell Culture 14.6.1.2. 3D Cell Culture 14.6.1.3. Perfusion Cell Culture 14.6.2. Lab-on-a-chip (LOC) 14.6.3. Ultra-high-throughput Screening 14.6.4. Bioinformatics 14.6.5. Label-free Technology 14.7. Asia Pacific High Throughput Screening Market Value Share Analysis, By End-User 14.8. Asia Pacific High Throughput Screening Market Forecast, By End-User 14.8.1. Pharmaceutical and Biotechnology Companies 14.8.2. Academic and Government Institutes 14.8.3. Contract Research Organizations 14.8.4. Other 14.9. Asia Pacific High Throughput Screening Market Value Share Analysis, By Application 14.10. Asia Pacific High Throughput Screening Market Forecast, By Application 14.10.1. Target Identification & Validation 14.10.2. Primary and Secondary Screening 14.10.3. Toxicology Assessment 14.10.4. Other Applications 14.11. Asia Pacific High Throughput Screening Market Value Share Analysis, by Country 14.12. Asia Pacific High Throughput Screening Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific High Throughput Screening Market Analysis, by Country 14.14. China High Throughput Screening Market Forecast, By Product and Services 14.14.1. Reagents & Assay Kits 14.14.2. Instruments 14.14.3. Consumables & Accessories 14.14.4. Software 14.14.5. Services 14.15. China High Throughput Screening Market Forecast, By Technology 14.15.1. Cell-based Assays 14.15.1.1. 2D Cell Culture 14.15.1.2. 3D Cell Culture 14.15.1.3. Perfusion Cell Culture 14.15.2. Lab-on-a-chip (LOC) 14.15.3. Ultra-high-throughput Screening 14.15.4. Bioinformatics 14.15.5. Label-free Technology 14.16. China High Throughput Screening Market Forecast, By End-User 14.16.1. Pharmaceutical and Biotechnology Companies 14.16.2. Academic and Government Institutes 14.16.3. Contract Research Organizations 14.16.4. Other 14.17. China High Throughput Screening Market Forecast, By Application 14.17.1. Target Identification & Validation 14.17.2. Primary and Secondary Screening 14.17.3. Toxicology Assessment 14.17.4. Other Applications 14.18. India High Throughput Screening Market Forecast, By Product and Services 14.18.1. Reagents & Assay Kits 14.18.2. Instruments 14.18.3. Consumables & Accessories 14.18.4. Software 14.18.5. Services 14.19. India High Throughput Screening Market Forecast, By Technology 14.19.1. Cell-based Assays 14.19.1.1. 2D Cell Culture 14.19.1.2. 3D Cell Culture 14.19.1.3. Perfusion Cell Culture 14.19.2. Lab-on-a-chip (LOC) 14.19.3. Ultra-high-throughput Screening 14.19.4. Bioinformatics 14.19.5. Label-free Technology 14.20. India High Throughput Screening Market Forecast, By End-User 14.20.1. Pharmaceutical and Biotechnology Companies 14.20.2. Academic and Government Institutes 14.20.3. Contract Research Organizations 14.20.4. Other 14.21. India High Throughput Screening Market Forecast, By Application 14.21.1. Target Identification & Validation 14.21.2. Primary and Secondary Screening 14.21.3. Toxicology Assessment 14.21.4. Other Applications 14.22. Japan High Throughput Screening Market Forecast, By Product and Services 14.22.1. Reagents & Assay Kits 14.22.2. Instruments 14.22.3. Consumables & Accessories 14.22.4. Software 14.22.5. Services 14.23. Japan High Throughput Screening Market Forecast, By Technology 14.23.1. Cell-based Assays 14.23.1.1. 2D Cell Culture 14.23.1.2. 3D Cell Culture 14.23.1.3. Perfusion Cell Culture 14.23.2. Lab-on-a-chip (LOC) 14.23.3. Ultra-high-throughput Screening 14.23.4. Bioinformatics 14.23.5. Label-free Technology 14.24. Japan High Throughput Screening Market Forecast, By End-User 14.24.1. Pharmaceutical and Biotechnology Companies 14.24.2. Academic and Government Institutes 14.24.3. Contract Research Organizations 14.24.4. Other 14.25. Japan High Throughput Screening Market Forecast, By Application 14.25.1. Target Identification & Validation 14.25.2. Primary and Secondary Screening 14.25.3. Toxicology Assessment 14.25.4. Other Applications 14.26. ASEAN High Throughput Screening Market Forecast, By Product and Services 14.26.1. Reagents & Assay Kits 14.26.2. Instruments 14.26.3. Consumables & Accessories 14.26.4. Software 14.26.5. Services 14.27. ASEAN High Throughput Screening Market Forecast, By Technology 14.27.1. Cell-based Assays 14.27.1.1. 2D Cell Culture 14.27.1.2. 3D Cell Culture 14.27.1.3. Perfusion Cell Culture 14.27.2. Lab-on-a-chip (LOC) 14.27.3. Ultra-high-throughput Screening 14.27.4. Bioinformatics 14.27.5. Label-free Technology 14.28. ASEAN High Throughput Screening Market Forecast, By End-User 14.28.1. Pharmaceutical and Biotechnology Companies 14.28.2. Academic and Government Institutes 14.28.3. Contract Research Organizations 14.28.4. Other 14.29. ASEAN High Throughput Screening Market Forecast, By Application 14.29.1. Target Identification & Validation 14.29.2. Primary and Secondary Screening 14.29.3. Toxicology Assessment 14.29.4. Other Applications 14.30. Rest of Asia Pacific High Throughput Screening Market Forecast, By Product and Services 14.30.1. Reagents & Assay Kits 14.30.2. Instruments 14.30.3. Consumables & Accessories 14.30.4. Software 14.30.5. Services 14.31. Rest of Asia Pacific High Throughput Screening Market Forecast, By Technology 14.31.1. Cell-based Assays 14.31.1.1. 2D Cell Culture 14.31.1.2. 3D Cell Culture 14.31.1.3. Perfusion Cell Culture 14.31.2. Lab-on-a-chip (LOC) 14.31.3. Ultra-high-throughput Screening 14.31.4. Bioinformatics 14.31.5. Label-free Technology 14.32. Rest of Asia Pacific High Throughput Screening Market Forecast, By End-User 14.32.1. Pharmaceutical and Biotechnology Companies 14.32.2. Academic and Government Institutes 14.32.3. Contract Research Organizations 14.32.4. Other 14.33. Rest of Asia Pacific High Throughput Screening Market Forecast, By Application 14.33.1. Target Identification & Validation 14.33.2. Primary and Secondary Screening 14.33.3. Toxicology Assessment 14.33.4. Other Applications 14.34. Asia Pacific High Throughput Screening Market Attractiveness Analysis 14.34.1. By Product and Services 14.34.2. By Technology 14.34.3. By End-User 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa High Throughput Screening Market Analysis 15.1. Key Findings 15.2. Middle East & Africa High Throughput Screening Market Overview 15.3. Middle East & Africa High Throughput Screening Market Value Share Analysis, By Product and Services 15.4. Middle East & Africa High Throughput Screening Market Forecast, By Product and Services 15.4.1. Reagents & Assay Kits 15.4.2. Instruments 15.4.3. Consumables & Accessories 15.4.4. Software 15.4.5. Services 15.5. Middle East & Africa High Throughput Screening Market Value Share Analysis, By Technology 15.6. Middle East & Africa High Throughput Screening Market Forecast, By Technology 15.6.1. Cell-based Assays 15.6.1.1. 2D Cell Culture 15.6.1.2. 3D Cell Culture 15.6.1.3. Perfusion Cell Culture 15.6.2. Lab-on-a-chip (LOC) 15.6.3. Ultra-high-throughput Screening 15.6.4. Bioinformatics 15.6.5. Label-free Technology 15.7. Middle East & Africa High Throughput Screening Market Value Share Analysis, By End-User 15.8. Middle East & Africa High Throughput Screening Market Forecast, By End-User 15.8.1. Pharmaceutical and Biotechnology Companies 15.8.2. Academic and Government Institutes 15.8.3. Contract Research Organizations 15.8.4. Other 15.9. Middle East & Africa High Throughput Screening Market Value Share Analysis, By Application 15.10. Middle East & Africa High Throughput Screening Market Forecast, By Application 15.10.1. Target Identification & Validation 15.10.2. Primary and Secondary Screening 15.10.3. Toxicology Assessment 15.10.4. Other Applications 15.11. Middle East & Africa High Throughput Screening Market Value Share Analysis, by Country 15.12. Middle East & Africa High Throughput Screening Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa High Throughput Screening Market Analysis, by Country 15.14. GCC High Throughput Screening Market Forecast, By Product and Services 15.14.1. Reagents & Assay Kits 15.14.2. Instruments 15.14.3. Consumables & Accessories 15.14.4. Software 15.14.5. Services 15.15. GCC High Throughput Screening Market Forecast, By Technology 15.15.1. Cell-based Assays 15.15.1.1. 2D Cell Culture 15.15.1.2. 3D Cell Culture 15.15.1.3. Perfusion Cell Culture 15.15.2. Lab-on-a-chip (LOC) 15.15.3. Ultra-high-throughput Screening 15.15.4. Bioinformatics 15.15.5. Label-free Technology 15.16. GCC High Throughput Screening Market Forecast, By End-User 15.16.1. Pharmaceutical and Biotechnology Companies 15.16.2. Academic and Government Institutes 15.16.3. Contract Research Organizations 15.16.4. Other 15.17. GCC High Throughput Screening Market Forecast, By Application 15.17.1. Target Identification & Validation 15.17.2. Primary and Secondary Screening 15.17.3. Toxicology Assessment 15.17.4. Other Applications 15.18. South Africa High Throughput Screening Market Forecast, By Product and Services 15.18.1. Reagents & Assay Kits 15.18.2. Instruments 15.18.3. Consumables & Accessories 15.18.4. Software 15.18.5. Services 15.19. South Africa High Throughput Screening Market Forecast, By Technology 15.19.1. Cell-based Assays 15.19.1.1. 2D Cell Culture 15.19.1.2. 3D Cell Culture 15.19.1.3. Perfusion Cell Culture 15.19.2. Lab-on-a-chip (LOC) 15.19.3. Ultra-high-throughput Screening 15.19.4. Bioinformatics 15.19.5. Label-free Technology 15.20. South Africa High Throughput Screening Market Forecast, By End-User 15.20.1. Pharmaceutical and Biotechnology Companies 15.20.2. Academic and Government Institutes 15.20.3. Contract Research Organizations 15.20.4. Other 15.21. South Africa High Throughput Screening Market Forecast, By Application 15.21.1. Target Identification & Validation 15.21.2. Primary and Secondary Screening 15.21.3. Toxicology Assessment 15.21.4. Other Applications 15.22. Rest of Middle East & Africa High Throughput Screening Market Forecast, By Product and Services 15.22.1. Reagents & Assay Kits 15.22.2. Instruments 15.22.3. Consumables & Accessories 15.22.4. Software 15.22.5. Services 15.23. Rest of Middle East & Africa High Throughput Screening Market Forecast, By Technology 15.23.1. Cell-based Assays 15.23.1.1. 2D Cell Culture 15.23.1.2. 3D Cell Culture 15.23.1.3. Perfusion Cell Culture 15.23.2. Lab-on-a-chip (LOC) 15.23.3. Ultra-high-throughput Screening 15.23.4. Bioinformatics 15.23.5. Label-free Technology 15.24. Rest of Middle East & Africa High Throughput Screening Market Forecast, By End-User 15.24.1. Pharmaceutical and Biotechnology Companies 15.24.2. Academic and Government Institutes 15.24.3. Contract Research Organizations 15.24.4. Other 15.25. Rest of Middle East & Africa High Throughput Screening Market Forecast, By Application 15.25.1. Target Identification & Validation 15.25.2. Primary and Secondary Screening 15.25.3. Toxicology Assessment 15.25.4. Other Applications 15.26. Middle East & Africa High Throughput Screening Market Attractiveness Analysis 15.26.1. By Product and Services 15.26.2. By Technology 15.26.3. By End-User 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America High Throughput Screening Market Analysis 16.1. Key Findings 16.2. South America High Throughput Screening Market Overview 16.3. South America High Throughput Screening Market Value Share Analysis, By Product and Services 16.4. South America High Throughput Screening Market Forecast, By Product and Services 16.4.1. Reagents & Assay Kits 16.4.2. Instruments 16.4.3. Consumables & Accessories 16.4.4. Software 16.4.5. Services 16.5. South America High Throughput Screening Market Value Share Analysis, By Technology 16.6. South America High Throughput Screening Market Forecast, By Technology 16.6.1. Cell-based Assays 16.6.1.1. 2D Cell Culture 16.6.1.2. 3D Cell Culture 16.6.1.3. Perfusion Cell Culture 16.6.2. Lab-on-a-chip (LOC) 16.6.3. Ultra-high-throughput Screening 16.6.4. Bioinformatics 16.6.5. Label-free Technology 16.7. South America High Throughput Screening Market Value Share Analysis, By End-User 16.8. South America High Throughput Screening Market Forecast, By End-User 16.8.1. Pharmaceutical and Biotechnology Companies 16.8.2. Academic and Government Institutes 16.8.3. Contract Research Organizations 16.8.4. Other 16.9. South America High Throughput Screening Market Value Share Analysis, By Application 16.10. South America High Throughput Screening Market Forecast, By Application 16.10.1. Target Identification & Validation 16.10.2. Primary and Secondary Screening 16.10.3. Toxicology Assessment 16.10.4. Other Applications 16.11. South America High Throughput Screening Market Value Share Analysis, by Country 16.12. South America High Throughput Screening Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America High Throughput Screening Market Analysis, by Country 16.14. Brazil High Throughput Screening Market Forecast, By Product and Services 16.14.1. Reagents & Assay Kits 16.14.2. Instruments 16.14.3. Consumables & Accessories 16.14.4. Software 16.14.5. Services 16.15. Brazil High Throughput Screening Market Forecast, By Technology 16.15.1. Cell-based Assays 16.15.1.1. 2D Cell Culture 16.15.1.2. 3D Cell Culture 16.15.1.3. Perfusion Cell Culture 16.15.2. Lab-on-a-chip (LOC) 16.15.3. Ultra-high-throughput Screening 16.15.4. Bioinformatics 16.15.5. Label-free Technology 16.16. Brazil High Throughput Screening Market Forecast, By End-User 16.16.1. Pharmaceutical and Biotechnology Companies 16.16.2. Academic and Government Institutes 16.16.3. Contract Research Organizations 16.16.4. Other 16.17. Brazil High Throughput Screening Market Forecast, By Application 16.17.1. Target Identification & Validation 16.17.2. Primary and Secondary Screening 16.17.3. Toxicology Assessment 16.17.4. Other Applications 16.18. Mexico High Throughput Screening Market Forecast, By Product and Services 16.18.1. Reagents & Assay Kits 16.18.2. Instruments 16.18.3. Consumables & Accessories 16.18.4. Software 16.18.5. Services 16.19. Mexico High Throughput Screening Market Forecast, By Technology 16.19.1. Cell-based Assays 16.19.1.1. 2D Cell Culture 16.19.1.2. 3D Cell Culture 16.19.1.3. Perfusion Cell Culture 16.19.2. Lab-on-a-chip (LOC) 16.19.3. Ultra-high-throughput Screening 16.19.4. Bioinformatics 16.19.5. Label-free Technology 16.20. Mexico High Throughput Screening Market Forecast, By End-User 16.20.1. Pharmaceutical and Biotechnology Companies 16.20.2. Academic and Government Institutes 16.20.3. Contract Research Organizations 16.20.4. Other 16.21. Mexico High Throughput Screening Market Forecast, By Application 16.21.1. Target Identification & Validation 16.21.2. Primary and Secondary Screening 16.21.3. Toxicology Assessment 16.21.4. Other Applications 16.22. Rest of South America High Throughput Screening Market Forecast, By Product and Services 16.22.1. Reagents & Assay Kits 16.22.2. Instruments 16.22.3. Consumables & Accessories 16.22.4. Software 16.22.5. Services 16.23. Rest of South America High Throughput Screening Market Forecast, By Technology 16.23.1. Cell-based Assays 16.23.1.1. 2D Cell Culture 16.23.1.2. 3D Cell Culture 16.23.1.3. Perfusion Cell Culture 16.23.2. Lab-on-a-chip (LOC) 16.23.3. Ultra-high-throughput Screening 16.23.4. Bioinformatics 16.23.5. Label-free Technology 16.24. Rest of South America High Throughput Screening Market Forecast, By End-User 16.24.1. Pharmaceutical and Biotechnology Companies 16.24.2. Academic and Government Institutes 16.24.3. Contract Research Organizations 16.24.4. Other 16.25. Rest of South America High Throughput Screening Market Forecast, By Application 16.25.1. Target Identification & Validation 16.25.2. Primary and Secondary Screening 16.25.3. Toxicology Assessment 16.25.4. Other Applications 16.26. South America High Throughput Screening Market Attractiveness Analysis 16.26.1. By Product and Services 16.26.2. By Technology 16.26.3. By End-User 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.4. M&A by Regions, Investment and Applications 17.2.5. M&A Key Players, Forward Integration and Backward 17.2.6. Integration 17.3. Company Profiles: Key Players 17.3.1. Charles River Laboratories International, Inc 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. Agilent Technologies, Inc 17.3.3. Danaher Corporation 17.3.4. Perkinelmer, Inc 17.3.5. Thermo Fisher Scientific Inc 17.3.6. Axxam S.P.A 17.3.7. Tecan Group Ltd 17.3.8. Bio-Rad Laboratories, Inc 17.3.9. Hamilton Company 17.3.10. Sigma-Aldrich Corporation 18. Primary Key Insights

About This Report

Report ID 54828
Category Life Science
Published Date March 2020
No of Pages 216
Contact Us